The company's unique patented platform allows for the implants to resorb into the body, avoiding unnecessary removal surgical interventions and providing a biologically natural and chemically neutral healing environment for bone renewal. Unlike other bioresorbable fixation implants, SDIP's compounds leave no acidic/basic by-products behind, preventing local inflammation and delayed tissue regeneration. The properties of SDIP can be customized to address different clinical needs, making it a safer option for patients. SDIP Innovations is committed to customer-driven strategies in their mission to revolutionize resorbable implants.